University Hospital Frankfurt MVZ GmbH, first laboratory offering Proclarix® in Germany
News 02.12.2020 Zurich-Schlieren, Switzerland and Frankfurt am Main, Germany, December 2, 2020 - The University Hospital Frankfurt MVZ (Medical Outpatient Care Center) GmbH, and Proteomedix, the Swiss cancer diagnostics company, announced today that Proclarix®, a new blood-based test for prostate cancer patient management, is made routinely available in Germany. ”Proclarix is an innovative...